Diabetes care devices are used to monitor and control blood glucose levels in diabetic patients. The main types of diabetes care devices are blood glucose test strips, insulin pens, syringes, pumps and injectors, lancing devices and equipment, continuous glucose monitoring devices and equipment, and blood glucose meters. Insulin pens are injection devices with a needle that delivers insulin into the subcutaneous tissue. The type of expenditures is public and private. The products used are instruments/equipment and disposables. The various end-users are hospitals and clinics, diagnostic laboratories, and others. The diabetes care devices market research report is one of a series of new reports from The Business Research Company that provides diabetes care devices market statistics, including diabetes care devices industry global market size, regional shares, competitors with a diabetes care devices market share, detailed diabetes care devices market segments, market trends and opportunities, and any further data you may need to thrive in the diabetes care devices industry. This diabetes care devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global diabetes care devices market grew from $58.63 billion in 2022 to $62.94 billion in 2023 at a compound annual growth rate (CAGR) of 7.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The diabetes care devices market is expected to grow to $80.06 billion in 2027 at a CAGR of 6.2%. Busy lifestyles and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as diabetes. Long working hours, limited physical activity, and unhealthy eating and drinking habits are major causes of diabetes. For instance, according to WHO data 2021, more than 95% of people with diabetes have type 2 diabetes. According to a World Health Organization (WHO) report, 74% of men and 64% of women in the UK, for instance, are expected to be overweight by 2030. These factors are expected to increase the patient pool of diabetes. For instance, according to IDF data 2021, nearly 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. These factors are expected to aid the market growth in the forecast period. The diabetes care devices market is expected to be limited by the high cost of the equipment, especially in low-income countries, where the cost related to diabetes devices is very high, despite insurance coverage. For example, in the US all the expenses related to diabetes treatment, which includes diabetes care devices can reach $1,000 a month. Thus, high costs associated with diabetes care devices and their accessories are likely to impede the market growth going forward. Pharmaceutical companies are investing in developing and commercializing glucose-responsive insulins (GRIs), providing significant opportunities for the development of new types of insulin delivery devices. For example, Novo Nordisk, a Danish pharmaceutical company, has planned to develop GRIs by acquiring UK biotech start-up Ziylo with an investment of $800 million. Companies such as Eli Lily and Sanofi have also planned research projects to develop GRIs. GRIs are 'smart' insulins that automatically activate or deactivate in response to changing glucose levels in the blood. They improve diabetes treatment efficacy and reduce the incidence of hyperglycemia and hypoglycemia. Major companies in the diabetes care devices market include Abbott Laboratories, Novo Nordisk, Medtronic Inc., Dexcom, Inc., F. Hoffmann-La Roche Ltd., Becton Dickinson, Insulet, Ypsomed, ConvaTec Group Plc, and B. Braun Group. North America was the largest region in the global diabetes care devices market in 2022. Western Europe was the second largest region in the global diabetes care devices market. The regions covered in the diabetes care devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the diabetes care devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The diabetes care devices market consists of sales of blood glucose monitoring devices, insulin delivery devices, smart insulin pens and others that are used for monitor and treat diabetes patient. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global diabetes care devices market is segmented - 1) By Type: Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables Subsegments Covered: Glucose Dehydrogenase, Glucose Oxidase, Pens, Injectors And Pumps, Syringes

Blood glucose meters are devices that are used to measure and display the amount of sugar (glucose) in the blood. The main product types of blood glucose meters market are electrode type blood glucose meter and the photoelectric blood glucose meter. Electrode type blood glucose meters are devices that contain electrodes to measure the current generated by an enzymatic reaction between glucose, an enzyme, and a mediator. The various applications included are type 1 diabetes, type 2 diabetes, and gestational diabetes, which are used by various end-users such as hospitals and home care. The blood glucose meters market research report is one of a series of new reports from The Business Research Company that provides blood glucose meters market statistics, including blood glucose meters industry global market size, regional shares, competitors with a blood glucose meters market share, detailed blood glucose meters market segments, market trends and opportunities, and any further data you may need to thrive in the blood glucose meters industry. This blood glucose meters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global blood glucose meters market size will grow from $15.64 billion in 2022 to $16.96 billion in 2023 at a compound annual growth rate (CAGR) of 8.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The blood glucose meters market size is expected to grow to $22.34 billion in 2027 at a CAGR of 7.1%. The rising prevalence of diabetes is driving the blood glucose meters market. The changing lifestyle, increase in alcohol consumption, physical inactivity, and unhealthy eating habits are leading to an increase in obesity across the globe. Such exponential growth in obese people is causing a stern increase in the purchase of blood glucose meters. Due to obesity, fat tissues release more fat molecules into the blood affecting insulin-responsive cells, which results in reduced insulin sensitivity, in turn, causing diabetes. According to the study by the International Diabetes Federation (IDF), there will be a 48% increase in diabetes around the world by 2045. According to the International Diabetes Federation (IDF) in 2021, nearly 537 million people were suffering from diabetes. The blood glucose meters market growth is restricted due to a lack of awareness of diabetes. Hypo unawareness is a common term used to describe people who have diabetes, especially type 1 diabetes, it is very difficult to notice when they have low blood glucose, hypoglycemia. Such lack of awareness of diabetes and its effects reduces the regular monitoring or check-ups relating to diabetes. For example, in 2021, 537 million adults had diabetes, but more than 1 in 4 did not know that they had the disease. Also, in 2021, According to the International Diabetes Federation (IDF), over one in two (54%) patients with diabetes do not recognize that they have diabetes. The launch of new products is a key trend gaining popularity in the blood glucose meters market. Companies in the market are focusing on the launch of new products to improve their product portfolio and strengthen their market position. For example, in January 2022, Roche, a Swiss multinational healthcare company, launched its new point-of-care blood glucose monitor designed for hospital professionals, with a companion device shaped like a touchscreen smartphone that will run its own apps. Glytec, a US based insulin management software company supplied software for the device, its Glucommander insulin-dosing program to help streamline the complex task of managing blood sugar levels during a patient's hospital stay. FDA regulates blood glucose meters. FDA has released its guidance for the accuracy of blood glucose meters. For blood glucose meters used in the home by patients with diabetes, FDA states that 95% of the measured blood glucose levels should be within 15% of the lab tested value and 99% of the measured values should be within 20% of the lab tested value. For the point of care blood glucose monitoring devices, 95% of the monitored values must be within the range of 12% for blood sugars more than 75mg/dl and must be within 12mg/dl for blood sugars less than 75mg/dl. Also, 98% of the meter values must be within 15% of the range for blood sugars more than 75mg/dl and must be within 15mg/dl for blood sugars less than 75mg/dl. In September 2021, B. Braun Melsungen AG, a German medical and pharmaceutical device company acquired Sterinova Inc for an undisclosed amount. This acquisition of Sterinova will continue to operate as a distinct subsidiary of B. Braun Melsungen AG. Sterinova Inc is a Canada-based company that develops, manufactures, and distributes ready-to-use sterile injectable products in syringes and premix bags. Major players in the blood glucose meters market are Abbott, Roche, Medtronics, Ascensia, Dexcom, Johnson & Johnson, Arkray, Acon, LifeScan, and Agamatrix Inc. North America was the largest region in the global blood glucose meters market in 2022. Western Europe was the second-largest region in the blood glucose meters market. The regions covered in the global blood glucose meters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries in the blood glucose meters market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia. The blood glucose meters consist of sales of electrode-type blood glucose meter and photoelectric blood glucose meter. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global blood glucose meters market is segmented - 1) By Product type: Electrode Type Blood Glucose Meter, Photoelectric Blood Glucose Meter 2) By End User: Hospitals, Home Care 3) By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes

A continuous blood glucose monitoring device enables a person to better regulate glucose levels throughout the day and experience fewer low blood glucose situations. The main types of components in continuous blood glucose monitoring devices are insulin pumps, sensors, transmitters, and receivers. Insulin pumps are small, computerized devices designed and programmed to deliver pre-determined doses of insulin in diabetic patients at specific intervals. These devices are used by type 1 diabetic patients, type 2 diabetic patients, gestational diabetes, and critical care patients which are used by various end-users, including hospitals, homecare diagnostics, and other end users. The continuous blood glucose monitoring market research report is one of a series of new reports from The Business Research Company that provides continuous blood glucose monitoring market statistics, including continuous blood glucose monitoring industry global market size, regional shares, competitors with a continuous blood glucose monitoring market share, detailed continuous blood glucose monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the continuous blood glucose monitoring industry. This continuous blood glucose monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global continuous blood glucose monitoring market size grew from $11.19 billion in 2022 to $12.5 billion in 2023 at a compound annual growth rate (CAGR) of 11.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The continuous blood glucose monitoring market size is expected to grow to $18.83 billion in 2027 at a CAGR of 10.8%. The increase in the prevalence of diabetes is expected to propel the growth of the continuous blood glucose monitoring market going forward. Diabetes is a health disease that occurs when the blood glucose levels fluctuate in the body. Blood glucose monitoring devices can aid in the detection of trends and patterns that give a better full picture of a diabetic's condition. For instance, according to the International Diabetes Federation, in 2020, around 463 million adults were affected by diabetes, among which 10.0% of them had type 1 diabetes, and 90.0% had type 2 diabetes. Therefore, the increasing prevalence of diabetes is driving the growth of the continuous blood glucose monitoring market. Technological advancements have emerged as a key trend gaining popularity in the continuous blood glucose monitoring market. Major companies operating in the continuous blood glucose monitoring market are focused on developing advanced technological solutions to strengthen their position in the market. For instance, in 2020, Philips, a Netherlands-based health technology company that manufactures glucose monitoring devices launched non-invasive monitors for COPD patients based on ExpiraFlow technology. The non-invasive monitors help health care professionals to detect and screen the expiratory flow limitation and can also be used in optimal home care therapy. In August 2020, Medtronic PLC., an Ireland-based medical device company, acquired Companion Medical for an undisclosed amount. The acquisition is intended to allow Medtronic PLC. to extend its product line and provide people with a one-of-a-kind and expansive ecosystem of support for their diabetes. Companion Medical Inc. is a US-based company that manufactures smart insulin pens which are used to monitor blood glucose. Major players in the continuous blood glucose monitoring market are Roche, Lifescan, Medtronic, Abbott, GlySens Inc., Arkray, Senseonics Holdings Inc., Glysure Limited, Nemaura, Tandem Diabetes Care, Goldsite Diagonostics Inc., AgaMatrix Inc., B. Braun Melsungen, Ypsomed Holding AG, Terumo, and Orsense Ltd. North America was the largest region in the continuous blood glucose monitoring market in 2022. The regions covered in the continuous blood glucose monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the continuous blood glucose monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The continuous blood glucose monitoring market consists of sales of real-time continuous glucose monitoring, and intermittently scanned continuous glucose monitoring. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global continous blood glucose monitoring market is segmented - 1) By Component: Insulin Pumps, Sensors, Transmitters, Receivers 2) By Application: Type 1 Diabetic Patients, Type 2 Diabetic Patients, Gestational Diabetes, Critical Care Patients 3) By End User: Hospitals, Homecare Diagnostics, Other End Users

Self-monitoring blood glucose (SMBG) device refers to portable instruments that can identify the possibilities of diabetes. These devices usually measure glucose levels by obtaining a small drop of blood from patients by pricking their fingers. International guidelines recommend this method for managing a patient’s diabetes successfully. The self-monitoring blood glucose (SMBG) device are used to measure the concentration of glucose in the blood. The main types of self-monitoring blood glucose (SMBG) devices are self-monitoring blood glucose meters, continuous glucose monitors, testing strips, and lancets. Self-monitoring blood glucose meters refer to handheld devices used by patients at home to check their blood glucose levels. Glucose meters usually require a drop of blood from the patient which is usually obtained from a pinprick. They are distributed by hospital pharmacies, retail pharmacies, online sales, and diabetes clinics & centers. These are used in various applications such as Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes. The Self-monitoring blood glucose (SMBG) devices market research report is one of a series of new reports from The Business Research Company that provides Self-monitoring blood glucose (SMBG) devices market statistics, including Self-monitoring blood glucose (SMBG) devices industry global market size, regional shares, competitors with an Self-monitoring blood glucose (SMBG) devices market share, detailed Self-monitoring blood glucose (SMBG) devices market segments, market trends and opportunities, and any further data you may need to thrive in the Self-monitoring blood glucose (SMBG) devices industry. This Self-monitoring blood glucose (SMBG) devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global self-monitoring blood glucose (smbg) devices market size grew from $13.24 billion in 2022 to $14.59 billion in 2023 at a compound annual growth rate (CAGR) of 10.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The self-monitoring blood glucose (smbg) devices market size is expected to grow to $20.29 billion in 2027 at a CAGR of 8.6%. The rising prevalence of diabetes is expected to propel the growth of the self-monitoring blood glucose device market going forward. Self-monitoring of blood glucose is a method in which person with diabetes use a glycemic reading gadget to measure their blood sugar (glucose meter) where they can change or monitor the effectiveness of their treatment (diet, exercise, insulin, antidiabetics) or see their physician based on the results of the test. For instance, according to the report published by International Diabetes Federation in 2021, there are 463 million individuals living with diabetes around the world in 2019 and increase to 537 million in 2021. Also, by the year 2030, the overall number of diabetics is expected to reach 643 million, and by 2045, it will reach 783 million. Therefore, the rising prevalence of diabetes is driving the growth of the self-monitoring blood glucose devices market. Technological advancement is a key trend gaining popularity in the self-monitoring blood glucose devices market. Major companies operating in the self-monitoring blood glucose devices market are focused on developing technologically advanced products to strengthen their position in the market. For instance, in September 2021, Know Labs Inc., a US-based company that manufactures glucose monitoring devices launched a new portable medical-grade glucose monitoring device named KnowU that utilizes Bio-RFID technology. This device is a non-invasive glucose monitoring machine that has a base that powers the device and displays readings and, a battery a powered monitor with Bio-RFID sensors that can be carried by the users to check sugar levels on the go. The KnowU is an affordable and convenient replacement for other expensive and painful blood glucose monitoring devices. In September 2021, Biocorp, a France-based manufacturer of medical devices including blood glucose monitoring has partnered with Novo Nordisk. This partnership was announced for the development and distribution of a Mallya smart add-on device for the FlexTouch pen that was developed by Novo Nordisk for people with diabetes. Biocorp and Novo Nordisk believe that with this partnership they can provide the best solutions for people with diabetes. Novo Nordisk is a Denmark-based healthcare company. Major players in the self-monitoring blood glucose(SMBG) devices market are Abbott Laboratories, Bionime Corporation, B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., LifeScan Inc., PHC Holdings Corporation, Home Diagnostics Inc., Terumo Pharmaceutical Solutions, ARKRAY Inc., Ypsomed Holding AG, Dexcom Inc., Medtronic PLC., Novo Nordisk, Glysens Incorporated, and Senseonics Holdings. North America was the largest region in the self-monitoring blood glucose (SMBG) devices market in 2022. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this self-monitoring blood glucose (SMBG) devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the self-monitoring blood glucose (SMBG) devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The self-monitoring blood glucose (SMBG) device market consists of sales of devices and instruments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global self monitoring blood glucose smbg devices market is segmented - 1) By Product: Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics & Centers 3) By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes

Database software is designed to create databases and store, manage, search, and retrieve information. The main types of database software are database operation management, and database maintenance management. Database operation management refers to database software that develops, and supports structured data to maximize the value of data across the enterprise. The database software is used by BFSI (banking, financial services, and insurance), IT and telecommunication, media and entertainment, healthcare, aerospace & defense, and other end-users and deployed through cloud and on-premise. The database software market research report is one of a series of new reports from The Business Research Company that provides database software market statistics, including database software industry global market size, regional shares, competitors with a database software market share, detailed database software market segments, market trends and opportunities, and any further data you may need to thrive in the database software industry. This database software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global database software market size will grow from $142.03 billion in 2022 to $163.93 billion in 2023 at a compound annual growth rate (CAGR) of 15.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global database software market size is expected to grow to $274.48 billion in 2027 at a CAGR of 13.8%. Businesses that engage with various types of data for analysis and making future decisions in today's data-driven world must be able to store data without difficulties and with simplicity. The rise of data-driven firms and e-commerce companies will significantly drive and fuel the database software market on a global basis. For instance, according to Forrester, businesses that rely on database management software tools to make decisions are 58% more likely to beat their revenue goals than non-data driven companies. Therefore, this continued increase in data driven businesses drives the database software market. A rising number of security concerns are expected to limit the growth of companies in the database software market during the forecast period. Security concerns have been increasing in recent times due to online availability of personal data. The database software store large databases online and these data of stakeholders/customers are accessed by teams around the globe which poses the potential for mistreatment of data. The data in the database software and other software faces security concerns including corporate/competitive espionage, fraud, ID theft, nations-state espionage and unauthorized sales of data to third-party. These issues restrict the growth of database software. For example, according to Cybersecurity Ventures, a global cyber economy researcher, cybercrime is expected to cost the world $10.5 trillion annually by 2025. The cybercrime costs cover stolen money, lost productivity, theft of intellectual property, theft of personal and financial data, damage and destruction of data, embezzlement, fraud, and others. Thus, the rising number of security concerns will limit the growth of the database software market. With Big Data gaining traction, database software companies are focusing on products to store and process Big Data. Databases such as SQL or NoSQL are tools to store, process and analyze Big Data. Efficient processing and storing of big data enable organizations to gather key insights and patterns from the available data and helps them in making intelligent decisions based on the same. Database software companies are therefore investing in adding new features to enable faster and more effective management of huge volumes of data. Some of the major database software tools include AWS DynamoDB, Azure Cosmos DB, and Amazon DocumentDB. In October 2021, Rocket Software, an American software development firm acquired the database and tools products of Zumasys Inc. for an undisclosed amount. The acquisition enables Rocket to innovate and offer products at scale. Zumasys Inc. is a US-based provider of MultiValue database software. Major players in the database software market are Oracle, Microsoft, IBM, SAP, Amazon, Redis, Teradata, Couch base, SQLite, MongoDB, Tandem, Mark Logic, ArangoDB, MariaDB, TablePlus, EnterpriseOB, RavenDB, NCR, Pervasive Software, FileMaker Inc., Software AG, HP (Vertica System), Informatica Corporation, InterSystems, iWay Software (subsidiary of IBI), MetaMatrix (subsidiary of Red Hat), Actian Corporation. North America was the largest region in the database software market in 2022. Asia-Pacific was the second largest region in the global database software market. The regions covered in the global database software market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the database software market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The database software market includes revenues earned by entities by developing and distributing software that are used to develop, modify and maintain database records and files. This software enables users to store data in the form of tables, fields and columns and recover them directly and/or through programmatic access. Database software is used for several reasons ranging from compiling client lists, maintaining bookkeeping tasks to running online web site. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global database software market is segmented - 1) By Type: Database Operation Management, Database Maintenance Management 2) By End User: BFSI [Banking and Financial Services], IT & Telecommunication, Media & Entertainment, Healthcare, Aerospace & Defense, Other End-Users 3) By Deployment: Cloud, On-Premise

The data science platform is a software that are used to analyze, organize, and transfer to assist businesses in developing analytic models and managing analytic data Data analysis across multiple platforms can assist businesses in gaining insights from user data and marketing campaigns, ultimately assisting in the improvement of strategy and revenue. The main types of products in the data science platform are solutions and services. The data science platform solutions help with data collection, data integration, and data visualization. These solutions help companies to plan strategies, uncover actionable insights from historic data. The different modes of deployment include cloud-based, on-premise, and are used by various sectors such as BFSI, telecommunication, transportation and logistics, healthcare, manufacturing, others. The data science platform market research report is one of a series of new reports from The Business Research Company that provides data science platform market statistics, including data science platform industry global market size, regional shares, competitors with a data science platform market share, detailed data science platform market segments, market trends and opportunities, and any further data you may need to thrive in the data science platform industry. This data science platform market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global data science platform market size grew from $74.77 billion in 2022 to $97.26 billion in 2023 at a compound annual growth rate (CAGR) of 30.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The data science platform market size is expected to grow to $285.78 billion in 2027 at a CAGR of 30.9%. The increase in demand for big data analytics is expected to propel the growth of the data science platform market during the forecast period. Big data analytics employs advanced analytic techniques to analyze a mixture of structured, semi-structured, and unstructured data collected by businesses and entities. Data science is the practice of extracting important information from data using advanced analytics techniques and scientific principles for enterprise decisions, strategic planning, and other purposes. For instance, according to Techjury, a US-based software company, the big data analytics sector is projected to reach $77 billion by 2023. Therefore, the increasing demand for big data analytics drives the growth of the data science platform market. The adoption of analytic apps is shaping the data science platform market. Major data science companies that use applications are focusing on adopting analytics applications that will help them better understand consumer behavior. Data analytic apps can tell users if the app is detected, compare downloads and in-app purchases, monitor, and evaluate KPIs, and give users in-app analytics insights, among other things. For instance, in May 2021, InCorta, Inc., a US-based company that provides data analytics software launched the Incorta Mobile app. The Incorta Mobile App allows Incorta users to access, evaluate, and analyze business information from anywhere, at any time, with the ability to drill down into particular transaction details. In January 2021, TIBCO Software Inc., a US-based enterprise data company acquired Information Builders for an undisclosed amount. Through this acquisition of Information Builders, analytics capabilities and data management will be added to the advanced TIBCO Connected Intelligence platform. Information Builders is a US-based company that hat specializes in data integration, data quality, and business intelligence. Major players in the data science platform market are Microsoft Corporation, Google, IBM, Oracle, Alteryx, SAP SE, Teradata, TIBCO Software, RapidMiner Inc., MathWorks, SAS Institute, Wolfram Research Inc., Dataiku, Fair Issac Corporation (FICO), and Altair. North America was the largest region in the data science platform market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the data science platform report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the data science platform market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The data science platform market includes revenues earned by entities by providing software tools that assist data scientists in analyzing data such as running, tracking, reproducing, sharing, and deploying models faster and more efficiently with powerful tools that speed up the process to enhance the organizational capability. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global data science platform market is segmented - 1) By Type: Solutions, Services 2) By Deployment: Cloud-Based, On-Premise 3) By End User: BFSI, Telecommunication, Transportation And Logistics, Healthcare, Manufacturing, Other End Users

Hand-held surgical devices and equipment are nonpowered, hand-held, or hand-manipulated devices such as scalpels, forceps, retractors, intended to be used in various general surgical procedures. The main products of handheld surgical devices are scalpels, forceps, retractors, dilators, graspers, and others. The forceps are handheld instruments used for holding objects. The various applications involved are neurosurgery, cardiovascular, orthopedic, plastic and reconstructive surgery, obstetrics and gynecology, and others that are used by various end-users such as hospitals, specialized clinics, long-term care centres, ambulatory surgery centres, and others. The handheld surgical devices market research report is one of a series of new reports from The Business Research Company that provides handheld surgical devices market statistics, including handheld surgical devices industry global market size, regional shares, competitors with a handheld surgical devices market share, detailed handheld surgical devices market segments, market trends and opportunities, and any further data you may need to thrive in the handheld surgical devices industry. This handheld surgical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global handheld surgical devices and equipment market size will grow from $6.07 billion in 2022 to $6.59 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The handheld surgical devices and equipment market size is expected to grow to $8.18 billion in 2027 at a CAGR of 5.6%. Increasing demand for aesthetic surgeries drives the handheld surgical devices and equipment market. The demand for aesthetic surgeries can be attributed to an increase in per capita disposable income. According to the ASPS data 2021, more than 15.5 million cosmetics procedures were performed in 2020 alone. Rhinoplasty (a nose job) was the top cosmetic surgery in 2020, with more than 352,000 surgeries performed. The competitive pricing among manufacturers will restrain the handheld surgical devices market. An increasing number of local manufacturers are offering handheld surgical instruments at lower prices compared to major global manufacturers, as a result, companies are competing heavily on price and often need high sales volumes to be profitable. The use of handheld devices and equipment in minimally invasive surgeries is increasing. The low cost of handheld instruments compared to robotic systems is the major factor for the increasing use of these devices in most surgical settings. Technical advancements in handheld surgical instruments are increasingly adopted by surgeons due to the improvement in the ease of use of these instruments. Medical devices are classified as Class I, Class II, and Class III devices by FDA based on their risks and the regulatory controls necessary to provide a reasonable assurance of safety and effectiveness. Hand-held surgical devices are nonpowered, hand-held, or hand-manipulated devices such as scalpels, forceps, retractors, intended to be used in various general surgical procedures. Hand-held surgical devices are categorized as Class I medical devices. Class I devices generally have the lowest risk to the patient and/or user. These devices are exempted from the premarket notification procedures 510(k). In October 2022, Aspen Surgical Products, a portfolio company of US-based Audax Private Equity, acquired Symmetry Surgical for an undisclosed amount. The acquisition would augment Aspen’s portfolio with additional brands and diversify its portfolio. Symmetry Surgical is a US-based manufacturer of surgical instrumentation. Major players in the handheld surgical devices market are B. Braun Melsungen AG, Medtronic, Smith & Nephew, Johnson & Johnson Services Inc., Integra Life Sciences Corporation, Zimmer Biomet, CooperSurgical Inc., Becton, Dickinson and Company, and Moria. North America was the largest region in global handheld surgical devices market in 2022. Western Europe was the second-largest region in global handheld surgical devices market. The regions covered in the handheld surgical devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the handheld surgical devices market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The handheld surgical devices and equipment market consists of sales of spatulas, dilators, graspers, auxiliary instruments, cutter instruments, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global handheld surgical devices and equipment market is segmented - 1) By Product: Scalpels, Forceps, Retractor, Dilators, Graspers, Other Products 2) By End-User: Hospitals, Specialized Clinics, Long-Term Care Centers, Ambulatory Surgery Centers, Other End Users 3) By Application, Neurosurgery, Cardiovascular, Orthopedic, Plastic & Reconstructive Surgery, Obstetrics & Gynecology, Other Applications

Digital asset management (DAM) is a software-based solution that allows organizations to store, retrieve, and use digital assets quickly. Digital assets are files like videos, music, photos, documents, and other media containing the rights to use them. DAM is an organization's content sharing and storage solution. The main types of digital asset management are solutions and services. The solutions allow users to develop, manage, distribute, monitor and locate digital assets while still managing the creative process. The various deployment modes include on-premises and cloud and are employed in different enterprise sizes such as large enterprises and small and medium-sized enterprises (SMEs). It is used in sales, marketing, IT, photography, graphics and designing, others and is implemented in various verticals such as media and entertainment, BFSI, retail, healthcare, automotive and manufacturing, others. The digital asset management (DAM) market research report is one of a series of new reports from The Business Research Company that provides digital asset management (DAM) market statistics, including digital asset management (DAM) industry global market size, regional shares, competitors with a digital asset management (DAM) market share, detailed digital asset management (DAM) market segments, market trends and opportunities, and any further data you may need to thrive in the digital asset management (DAM) industry. This digital asset management (DAM) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global digital asset management market size grew from $5.05 billion in 2022 to $5.86 billion in 2023 at a compound annual growth rate (CAGR) of 16.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The digital asset management market size is expected to grow to $10.71 billion in 2027 at a CAGR of 16.3%. The increasing prevalence of cloud-based digital asset management (DAM) solutions is projected to propel the growth of the digital asset management (DAM) market. Cloud-based digital asset management (DAM) is a platform that enables businesses to handle, store, and organize their resources in a cloud-based environment. Any organization that uses resources for packaging, marketing, advertisement, or any other business-related activity would benefit from a cloud DAM. For instance, in 2020, according to the report by Gartner Inc., a US-based technological research and consulting firm, around 80% of business owners intend to permit staff to work remotely at least occasionally and 47% stated they would permit full-time remote work for staff members which has facilitatedthe need of digital assest management solution in an organization to manage business operations remotely. Additionally, marketing teams squander approximately a day per week looking for assets, a digital asset management (DAM) recovers wasted time and can significantly increase productivity by 30–35%. Therefore, the increasing prevalence of cloud-based digital asset management (DAM) solutions drives the growth of the digital asset management (DAM) market. Technological advancement is a key trend shaping the digital asset management (DAM) market. Major companies operating in the digital asset management (DAM) sector are focused on developing technologically advanced solutions for digital asset management (DAM). For instance, in July 2020, Sitecore, a US-based software company launched version 3.4 of its Sitecore Content Hub solution, which includes new and improved workflow and third-party integration capabilities. Sitecore Content Hub version 3.4 adds artificial intelligence (AI) and video technologies to its Digital Asset Management (DAM) platform, allowing for the automated production of metadata and transcripts for video, as well as time and range-based annotation, cropping, and subtitles. In April 2021, Hyland Software, a US-based software company acquired Nuxeo for an undisclosed amount. Through this acquisition, Nuxeo reinforces Hyland’s commitment to cloud-native platforms and open-source communities while expanding its global footprint with additional team members, customers, and partners. Nuxeo is a US-based company that offers digital asset management solutions. Major players in the digital asset management market are Adobe, OpenText, MediaBeacon, Aprimo, Bynder, Widen, Cognizant, CELUM, Canto, Northplains, Oracle Corporation, IBM Corporation, Nuxeo, Digizuite, Cloudinary, MediaValet, Extensis, QBNK Holding AB, Dell Technologies, IntelligenceBank, Sitecore, Wedia, Censhare, BrandMaker, Brandfolder, Bright, MarcomCentral, Filecamp, and Webdam Inc., North America was the largest region in the digital asset management market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital asset management (DAM) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the digital asset management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The digital asset management market includes revenues earned by entities by providing software that automates the processes for finding, storing, and organizing the digital content of an organization to the central store and managing it to enhance business operations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global digital asset management market is segmented - 1) By Type: Solution, Services 2) By Deployment Type: On-Premises, Cloud 3) By Enterprise Size: Large Enterprises, Small and Medium-sized Enterprises (SMEs) 4) By Application: Sales, Marketing, IT, Photography, Graphics and Designing, Other Applications 5) By End User: Media and Entertainment, BFSI, Retail, Healthcare, Automotive and Manufacturing, Other End Users